Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) Net Margin (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Net Margin for 3 consecutive years, with 139.16% as the latest value for Q1 2026.

  • Quarterly Net Margin rose 2541.0% to 139.16% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 176.92% through Jan 2026, up 369.0% year-over-year, with the annual reading at 210.88% for FY2025, 15168.0% up from the prior year.
  • Net Margin for Q1 2026 was 139.16% at Kestra Medical Technologies, up from 145.29% in the prior quarter.
  • The five-year high for Net Margin was 133.32% in Q3 2025, with the low at 321.15% in Q2 2025.
  • Average Net Margin over 3 years is 195.92%, with a median of 164.57% recorded in 2025.
  • Peak annual rise in Net Margin hit 11852bps in 2025, while the deepest fall reached -7968bps in 2025.
  • Over 3 years, Net Margin stood at 161.05% in 2024, then grew by 10bps to 145.29% in 2025, then grew by 4bps to 139.16% in 2026.
  • According to Business Quant data, Net Margin over the past three periods came in at 139.16%, 145.29%, and 133.32% for Q1 2026, Q4 2025, and Q3 2025 respectively.